Full video transcriptClick to expand
Auto-generated transcript of @socalurologyinstitute's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00As we age, there are libido differences between the genders.
- 0:04So many couples, 40, 50, and above, the man's libido is higher than the woman's.
- 0:11It's a common issue.
- 0:13It has to do with age.
- 0:14It has to do with hormones.
- 0:16And then we take men, we treat men, and we take their testosterone and make it higher.
- 0:23But their spouses' libido hasn't changed, so the disparity can be greater.
- 0:29So men often come in on testosterone replacement and say, I feel great.
- 0:33I feel younger and stronger and more youthful, but my libido has enhanced, but my wife or
- 0:39my girlfriend's libido hasn't.
- 0:42What can you do for her?
- 0:43Well, some women do get treated with hormone replacement.
- 0:48Some don't.
- 0:49So when I talk to couples who have already a disparity in their libido, it's important to
- 0:54explain to men that that disparity will probably increase and may or may not be a problem in
- 1:01context of the relationship.
TRT and libido mismatches: what the evidence actually says
Quick answer
TRT reliably increases sexual desire in clinically hypogonadal men, which can widen a pre-existing libido gap in long-term couples when the female partner's desire is not concurrently addressed. Some postmenopausal women may benefit from low-dose testosterone therapy for hypoactive sexual desire disorder, though this remains off-label in most jurisdictions and requires individualized assessment. Pre-treatment couples counseling is an underutilized but evidence-supported component of responsible TRT care.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 11 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT and libido mismatches: what the evidence actually says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
TRT and libido mismatches: what the evidence actually says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "TRT and libido mismatches: what the evidence actually says" from Dr Gary Bellman | SoCalUrology. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: TRT reliably increases sexual desire in clinically hypogonadal men, which can widen a pre-existing libido gap in long-term couples when the female partner's desire is not concurrently addressed.
The reason this review is not generic is the source wording and the canonical claim label "trt can testosterone replacement cause relationship issues regar." In this clip, the useful excerpt is: "As we age, there are libido differences between the genders." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
TRT reliably increases sexual desire in clinically hypogonadal men, which can widen a pre-existing libido gap in long-term couples when the female partner's desire is not concurrently addressed.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- TRT reliably increases sexual desire in clinically hypogonadal men, which can widen a pre-existing libido gap in long-term couples when the female partner's desire is not concurrently addressed. Some postmenopausal women may benefit from low-dose testosterone therapy for hypoactive sexual desire disorder, though this remains off-label in most jurisdictions and requires individualized assessment. Pre-treatment couples counseling is an underutilized but evidence-supported component of responsible TRT care.
- Snyder et al. (2016, NEJM) confirmed testosterone therapy significantly improved sexual desire in hypogonadal men compared to placebo in a randomized controlled trial.
- Desire discrepancy is one of the most common sexual complaints in long-term couples, per sex therapy research, and tends to increase with age independent of TRT.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Snyder et al. (2016, NEJM) confirmed testosterone therapy significantly improved sexual desire in hypogonadal men compared to placebo in a randomized controlled trial.
- Desire discrepancy is one of the most common sexual complaints in long-term couples, per sex therapy research, and tends to increase with age independent of TRT.
- Low-dose testosterone therapy for women with low sexual desire has Level 1 evidence support in postmenopausal populations (Davis et al., 2019, Lancet Diabetes and Endocrinology), but is off-label in most countries.
- TRT's libido-boosting effect is strongest in men with confirmed hypogonadism; men with borderline testosterone levels may see minimal desire changes (Isidori et al., 2005, Clinical Endocrinology).
- The creator correctly flagged that couples should be counseled about potential libido mismatch before starting TRT, a conversation that most online TRT content skips entirely.
- Psychological factors, relationship satisfaction, and stress are major independent drivers of sexual desire in both sexes and can override hormonal changes in either direction.
- Female hormone replacement for low libido is not a simple solution: dosing, monitoring, and patient selection require individualized clinical assessment, not a one-size approach.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @socalurologyinstitute actually say?
The creator, apparently a urologist, made a specific and clinically grounded point: as men age, their libido tends to outpace their female partners', and when you put a man on testosterone replacement therapy (TRT), you widen that gap further. "The disparity can be greater," he said, because treatment boosts male desire while the partner's libido stays flat. He also noted that some women can be treated with hormone replacement, and that couples should be counseled about this before starting TRT. This is practical, relationship-aware clinical advice that you rarely hear in the testosterone content space, which is usually just before-and-after body composition posts.
He did not make exaggerated claims about TRT fixing everything, did not prescribe doses, and framed the libido shift as something that "may or may not be a problem" depending on the relationship. That kind of measured language is notably absent from most TRT content online.
Does the science back this up?
Yes, largely. The age-related divergence in libido between men and women is well-documented, and TRT's effect on male sexual desire is one of the most consistently replicated findings in men's health research. The claim holds up.
A 2016 placebo-controlled trial published in the New England Journal of Medicine (Snyder et al., 2016, NEJM) confirmed that testosterone treatment in men with low levels significantly improved sexual desire and activity compared to placebo. On the female side, research consistently shows libido in women declines with age and menopause, driven partly by falling estrogen and testosterone, but the trajectory and causes differ from men's. A meta-analysis by Davis et al. (2019, Lancet Diabetes and Endocrinology) found that low-dose testosterone therapy in postmenopausal women did improve sexual function, which supports the creator's mention that some female partners "do get treated with hormone replacement." The couple-level libido mismatch as a real clinical phenomenon is also described in sex therapy literature, including work by McCarthy and Metz (2008, Journal of Sex and Marital Therapy).
What did they get wrong (or right)?
Mostly right, with one notable omission. The framing that age causes male libido to stay higher than female libido in couples over 40 is broadly accurate, but it oversimplifies a complex picture. The creator got the core claim right.
What he skipped is that TRT does not uniformly raise libido in all men. The effect is strongest in men who are genuinely hypogonadal. Men with low-normal or borderline testosterone levels see more modest or inconsistent libido benefits, as noted in a systematic review by Isidori et al. (2005, Clinical Endocrinology). So the framing that TRT reliably amplifies male desire enough to widen the couple gap every time is a slight overclaim. For some men on TRT, libido improvements are minimal.
He also did not mention that psychological factors, relationship quality, and stress are major drivers of desire in both sexes, sometimes outweighing hormonal status entirely. That context matters when counseling couples. Still, he's a urologist speaking in a short-form video, not writing a textbook, and what he said is defensible and clinically honest.
What should you actually know?
The libido mismatch problem in TRT is real, underdiscussed, and worth taking seriously before you start treatment. Most TRT content focuses on muscle, energy, and mood. Almost none of it addresses what happens to your relationship when your sexual appetite shifts and your partner's does not.
If you are considering TRT, ask your provider directly about this. Evidence supports low-dose testosterone therapy for women with hypoactive sexual desire disorder (HSDD), particularly postmenopausal women (Islam et al., 2019, Cochrane Database of Systematic Reviews), though this use is off-label in many countries and requires careful monitoring. The creator is right that female hormone therapy is an option, but it is not a simple fix, and not every woman will want it or benefit from it. Couples counseling or sex therapy should be on the table as a parallel intervention, not an afterthought. The best TRT outcomes, including relationship satisfaction, tend to happen when both partners are involved in the conversation from the start.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Dr Gary Bellman | SoCalUrology · TikTok creator
6.8K views on this video
Can testosterone replacement cause relationship issues regarding higher libido? #menshealth #fypシ #urologylife #testosteronetherapy #trttransformation #trt #testosteronelevels #trttransformation #trt #testosteronebooster #hcg
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about snyder et al. (2016, nejm) confirmed testosterone therapy significantly improved?
Snyder et al. (2016, NEJM) confirmed testosterone therapy significantly improved sexual desire in hypogonadal men compared to placebo in a randomized controlled trial.
What does the video say about desire discrepancy?
Desire discrepancy is one of the most common sexual complaints in long-term couples, per sex therapy research, and tends to increase with age independent of TRT.
What does the video say about low-dose testosterone therapy for women with low sexual desire has?
Low-dose testosterone therapy for women with low sexual desire has Level 1 evidence support in postmenopausal populations (Davis et al., 2019, Lancet Diabetes and Endocrinology), but is off-label in most countries.
What does the video say about trt's libido-boosting effect?
TRT's libido-boosting effect is strongest in men with confirmed hypogonadism; men with borderline testosterone levels may see minimal desire changes (Isidori et al., 2005, Clinical Endocrinology).
What does the video say about the creator correctly flagged?
The creator correctly flagged that couples should be counseled about potential libido mismatch before starting TRT, a conversation that most online TRT content skips entirely.
What does the video say about psychological factors, relationship satisfaction,?
Psychological factors, relationship satisfaction, and stress are major independent drivers of sexual desire in both sexes and can override hormonal changes in either direction.
Sources & references
- [1]Snyder et al., 2016
- [2]Davis et al. (2019)
- [3]Isidori et al. (2005)
- [4]Islam et al., 2019
- [5]McCarthy and Metz (2008)
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by Dr Gary Bellman | SoCalUrology, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.